Nifty
:
23850.90
Sensex
:
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)
Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Sotac Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: Not Listed | NSE: SOTAC

NSE BSE
158.60
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  142.00
  •  160.00
  •  142.00
  •  140.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  25200
  •  38.31
  •  202.80
  •  87.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 131.22
  • 22.83
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 152.66
  • N/A
  • 2.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 72.85%
  • 11.60%
  • 6.01%
  • FII
  • DII
  • Others
  • 8.88%
  • 0.00%
  • 0.66%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.38

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 6.74

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 14.12

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
25.25
24.97
1.12%
0.00
0.00
0
25.74
19.65
30.99%
0.00
0.00
0
Expenses
23.03
22.63
1.77%
0.00
0.00
0
22.83
17.88
27.68%
0.00
0.00
0
EBITDA
2.21
2.34
-5.56%
0.00
0.00
0
2.92
1.77
64.97%
0.00
0.00
0
EBIDTM
8.78%
9.35%
0.00%
0.00%
11.33%
9.02%
0.00%
0.00%
Other Income
0.25
0.23
8.70%
0.00
0.00
0
0.61
0.01
6,000.00%
0.00
0.00
0
Interest
0.42
0.46
-8.70%
0.00
0.00
0
0.99
0.27
266.67%
0.00
0.00
0
Depreciation
0.75
0.60
25.00%
0.00
0.00
0
0.83
0.56
48.21%
0.00
0.00
0
PBT
1.30
1.50
-13.33%
0.00
0.00
0
1.47
0.95
54.74%
0.00
0.00
0
Tax
-0.05
0.52
-
0.00
0.00
0
0.60
0.37
62.16%
0.00
0.00
0
PAT
1.35
0.98
37.76%
0.00
0.00
0
0.88
0.58
51.72%
0.00
0.00
0
PATM
5.33%
3.94%
0.00%
0.00%
3.40%
2.93%
0.00%
0.00%
EPS
1.31
0.98
33.67%
0.00
0.00
0
0.82
0.71
15.49%
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Net Sales
-
103.83
77.48
73.15
Net Sales Growth
-
34.01%
5.92%
 
Cost Of Goods Sold
-
79.61
57.27
56.06
Gross Profit
-
24.22
20.21
17.10
GP Margin
-
23.33%
26.08%
23.38%
Total Expenditure
-
95.28
70.17
66.98
Power & Fuel Cost
-
1.28
1.00
0.78
% Of Sales
-
1.23%
1.29%
1.07%
Employee Cost
-
2.05
2.58
2.24
% Of Sales
-
1.97%
3.33%
3.06%
Manufacturing Exp.
-
6.78
4.16
4.28
% Of Sales
-
6.53%
5.37%
5.85%
General & Admin Exp.
-
4.37
3.81
1.47
% Of Sales
-
4.21%
4.92%
2.01%
Selling & Distn. Exp.
-
0.93
0.99
0.27
% Of Sales
-
0.90%
1.28%
0.37%
Miscellaneous Exp.
-
0.27
0.36
1.89
% Of Sales
-
0.26%
0.46%
2.58%
EBITDA
-
8.55
7.31
6.17
EBITDA Margin
-
8.23%
9.43%
8.43%
Other Income
-
0.49
0.35
0.22
Interest
-
1.74
2.04
0.57
Depreciation
-
3.10
2.28
1.13
PBT
-
4.20
3.35
4.69
Tax
-
0.38
1.64
1.82
Tax Rate
-
9.57%
41.73%
38.81%
PAT
-
4.28
2.88
2.88
PAT before Minority Interest
-
3.58
2.29
2.88
Minority Interest
-
0.70
0.59
0.00
PAT Margin
-
4.12%
3.72%
3.94%
PAT Growth
-
48.61%
0.00%
 
EPS
-
3.89
2.62
2.62

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Shareholder's Funds
45.26
19.46
6.62
Share Capital
11.05
8.05
2.30
Total Reserves
34.21
1.94
4.32
Non-Current Liabilities
10.84
8.14
1.01
Secured Loans
10.76
7.64
0.97
Unsecured Loans
1.37
0.13
0.00
Long Term Provisions
0.14
0.10
0.06
Current Liabilities
43.73
45.81
27.61
Trade Payables
28.89
25.39
19.74
Other Current Liabilities
4.18
7.53
1.50
Short Term Borrowings
9.88
10.82
5.19
Short Term Provisions
0.78
2.06
1.18
Total Liabilities
103.90
73.64
35.24
Net Block
35.51
25.92
8.80
Gross Block
45.60
32.91
13.55
Accumulated Depreciation
10.09
6.99
4.75
Non Current Assets
43.25
26.50
9.36
Capital Work in Progress
5.12
0.04
0.00
Non Current Investment
2.10
0.00
0.39
Long Term Loans & Adv.
0.53
0.54
0.17
Other Non Current Assets
0.00
0.00
0.00
Current Assets
60.65
47.14
25.88
Current Investments
0.00
0.00
0.00
Inventories
18.01
13.64
5.39
Sundry Debtors
26.29
14.74
12.25
Cash & Bank
3.42
9.68
0.03
Other Current Assets
12.93
0.73
0.07
Short Term Loans & Adv.
12.79
8.34
8.13
Net Current Assets
16.92
1.33
-1.73
Total Assets
103.90
73.64
35.24

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
-16.12
8.14
6.35
PBT
3.96
3.93
4.69
Adjustment
2.31
4.33
3.43
Changes in Working Capital
-20.31
1.57
0.08
Cash after chg. in Working capital
-14.03
9.83
8.21
Interest Paid
0.00
0.00
0.00
Tax Paid
-2.09
-1.68
-1.86
Other Direct Exp. Paid
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
Cash From Investing Activity
-19.68
-11.67
-3.52
Net Fixed Assets
0.28
-6.96
Net Investments
-7.50
-4.00
Others
-12.46
-0.71
Cash from Financing Activity
29.54
13.14
-2.83
Net Cash Inflow / Outflow
-6.26
9.61
0.00
Opening Cash & Equivalents
9.68
0.08
0.02
Closing Cash & Equivalent
3.42
9.68
0.03

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
40.96
12.41
8.23
ROA
4.03%
4.20%
8.23%
ROE
12.96%
27.53%
63.16%
ROCE
10.22%
21.50%
31.31%
Fixed Asset Turnover
2.65
3.34
4.12
Receivable days
72.11
63.58
45.25
Inventory Days
55.63
44.84
25.51
Payable days
124.45
143.83
106.65
Cash Conversion Cycle
3.30
-35.41
-35.90
Total Debt/Equity
0.55
2.21
1.12
Interest Cover
3.28
2.92
9.24

Annual Reports:

FY 2024
FY 2023

News Update:


  • Sotac Pharmaceutical - Quarterly Results
    13th Aug 2024, 12:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.